![]() |
The objective of the NASA report is to track HIV/AIDS spending from 2007 to 2009 from various sources of financing covering both public and external funds. The aim of this initiative is to inform policy-makers, program managers, and the donor community on the magnitude and profile of HIV/AIDS expenditures in the country and guide them in their planning and decisionmaking activities. |
Download Publication |
![]() |
Comprehensive information about national spending on AIDS response is crucial for health policy development and evaluation. Dehong Prefecture of Yunnan Province is one of the areas hardest hit by HIV in China. Since 1989, when the first 146 HIV-infected injecting drug users (IDUs) were identified in Dehong, this area with 1.1 million of people reported a cumulative total of 17,590 HIV cases by the end of 2010. Studies conducted suggest that the population prevalence for HIV infections in Dehong Prefecture is estimated to be 1.3%. IDUs make up the majority of the people living with HIV (PLHIV) in Dehong Prefecture, accounting for more than a half of the total number of estimated HIV cases in Dehong with high estimated HIV prevalence. HIV transmission mode has been changing gradually over the recent years from intravenous drug use to heterosexual and homosexual transmission. This study provides a comprehensive overview of the overall level and composition of major investments in national AIDS response in Dehong Prefecture introducing National AIDS Spending Assessment (NASA) as a method for the purpose.
|
Download Publication |
![]() |
Following universal access to antiretroviral therapy in Thailand, evidence from National AIDS Spending Assessment indicates a decreasing proportion of expenditure on prevention interventions. To prompt policymakers to revitalize HIV prevention, this study identifies a comprehensive list of HIV/AIDs preventive interventions that are likely to be effective and cost-effective in Thailand. Download this publication |
![]() |
HIV has devastated numerous countries in sub-Saharan Africa and is a dominant health force in many other Source: Amico P, Aran C, Avila C (2010) HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country Study. PLoS ONE 5(9): e12997. doi:10.1371/journal.pone.0012997 Download this publication |
![]() |
The India AIDS Initiative (Avahan) project is involved in rapid scale-up of HIV-prevention interventions in high-risk populations. This study examines the cost variation of 107 non-governmental organisations (NGOs) implementing targeted interventions, over the start up (defined as period from project inception until services to the key population commenced) and first 2 years of intervention. Download this publication |
![]() |
In many respects, Cambodia has made exceptional progress in addressing HIV/AIDS since it was first detect- ed in 1991. While the estimated number of new infections grew to reach almost 15,500 annually in the early 1990s, it had been reduced to about 2,100 by 2009. Download this publication |
![]() |
This note is intended as a short summary of the recent consultation to share immediately with partners to indicate meeting outcomes and action points while the extended meeting report is finalized. |
![]() |
People who inject drugs should benefit from the large increases in the global resources available for HIV. However, it is difficult to measure how much of global HIV spending actually goes into harm reduction. Although harm reduction is relatively invisible in national and international budgets, it is possible to calculate a plausible estimate of HIVrelated harm reduction expenditure in low and middle income countries between 2007 and 2009. These results demonstrate the degree to which the international community is failing to address the issue of HIV among injecting drug using populations.
|
![]() |
According to the latest available estimates, there are currently about 2.5 million people living with HIV or AIDS in India, corresponding to a HIV prevalence rate of 0.36 percent for the population ages 15–49 (IIPS 2007). While HIV prevalence thus remains relatively low, there are sev- eral factors that are unique to India’s HIV epidemic, and need to be taken into account when assessing the impact of HIV and AIDS. Download this publication |